The BridgeTech Program, run and administered by QUT, is hosting some of Australia’s leading MedTech entrepreneurs and industry experts in order to provide an unrivalled speaker series for its participants.
Talks from MedTech company founders, IP and patent specialists, executives from incubators and accelerators, successful startup founders and grant and funding specialists are among the backgrounds that are included in the line-up for the BridgeTech speaker series.
The BridgeTech Program trains participants on the complexities of the commercialisation process for medical devices so that participants will be able to more effectively navigate this path for their own projects and so that the Australian Medtech sector will be able to grow and expand.
Having already hosted seminars in Brisbane and Melbourne earlier in the year, the speaker series has now moved for the first time, to WA where a joint event was held in Perth on September 7th.
The BridgeTech Program’s consortium partner, University of Western Australia hosted the seminar in coordination with their own ‘WA BioInnovation Showcase and Networking Event’ at the Ernst & Young building in Perth, who also supported the event.
The impressive line-up of speakers for the BridgeTech seminar, included:
- Arthur Ong, Founder and Managing Director, Progressive Medical and HIVUM Digital
- Dr David Glance, Director, UWA Centre for Software Practice
- Andrew Burton, Government Grants and Tax Incentives Specialist, Ernst & Young.
Also speaking at the event in an opening address was Dr Dan Grant, CEO, MTPConnect. Dr Grant says MTPConnect is proud supporter of the BridgeTech Program.
“Providing mid-career researchers and entrepreneurs with opportunities to learn more about legal, financial, clinical and regulatory frameworks is invaluable,” Dr Grant said.
“The speaker series in Perth does just that, and it was great to see so many in attendance, keen to discuss ways to more effectively capitalise on the great research taking place in Western Australia.”
MTPConnect has provided support and backing for the BridgeTech Program at other events and will also be announcing the opening of their new WA node in Perth.
Hearing from some of the nation’s leaders in the medical device sector provides participants with a plethora of perspective and experience on the commercialisation pathway whether it be related to funding, regulation, IP, innovation, scientific or clinical backgrounds.
Comprising Australian MedTech companies, universities and industry associations, the BridgeTech Program consortium has 21 partners who provide input and advice, including:
- The Actuator
- Agilent Technologies
- AusBiotech
- Australia China Technology Incubator
- Cochlear
- Deakin University
- Flinders University
- Gadens
- Hydrix
- IDE Group
- Life Sciences Queensland, Magnetica
- Macquarie University
- MTAA
- Queensland University of Technology
- Siemens Healthcare
- Stryker
- University of Melbourne
- University of New South Wales
- University of Newcastle
- University of Western Australia.
The BridgeTech Program includes online training modules, an occasional speaker series and a 3-day training workshop that will strengthen the new skills and networks created throughout the program.
Specifically, The BridgeTech Program aims to train researchers and entrepreneurs on the scientific, legal, financial, clinical, regulatory and reimbursement disciplines related to taking new medical technology to market.
For more information, email bridgetech.program@qut.edu.au.